United States· US:64842-1020_15b86e86-8940-44e3-921c-2e0b97180ea1

LONSURF

A medicinal product containing trifluridine; tipiracil hydrochloride, registered in United States by Taiho Pharmaceutical Co., Ltd..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLONSURFATC—REGISTER NO.US:64842-1020_15b86e8…PACKS LISTED6CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TRIFLURIDINE; TIPIRACIL HYDROCHLORIDE
Manufacturer
Taiho Pharmaceutical Co., Ltd.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    64842-1020-1
  • ndc11
    64842-1020-2
  • ndc11
    64842-1020-3
  • ndc11
    6484210201
    20 TABLET, FILM COATED in 1 BOTTLE (64842-1020-1)
  • ndc11
    6484210202
    40 TABLET, FILM COATED in 1 BOTTLE (64842-1020-2)
  • ndc11
    6484210203
    60 TABLET, FILM COATED in 1 BOTTLE (64842-1020-3)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trifluridine; tipiracil hydrochloride in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trifluridine; tipiracil hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Belgium · Trifluridine/Tipiracil Eugia
  • Spain · Trifluridina/Tipiracilo Eugia
  • Iceland · Lonsurf
  • Liechtenstein · Lonsurf
  • Luxembourg · Trifluridine/Tipiracil Eugia
  • Netherlands · Trifluridine, Tipiracil Eugia
  • Norway · Lonsurf
  • Portugal · Trifluridina + Tipiracilo Eugia

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1d47b61-074a-4ffd-a57b-131716a7cb1c
GET /v1/drugs/c1d47b61-074a-4ffd-a57b-131716a7cb1c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "20; 8.19",
  "substance": "TRIFLURIDINE; TIPIRACIL HYDROCHLORIDE",
  "productndc": "64842-1020",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "NDA207981",
  "marketing_category": "NDA"
}

See everything about trifluridine; tipiracil hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.